FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244687613> ?p ?o ?g. }

• W4244687613 endingPage "1688" @default.
• W4244687613 startingPage "1677" @default.
• W4244687613 abstract "This study investigates the effects of dapagliflozin on the visceral adiposity index (VAI), lipid accumulation product (LAP), product of triglycerides and glucose (TyG) and triglycerides to HDL-cholesterol ratio (TG/HDL-C) in patients with type 2 diabetes mellitus (T2D). In this real-life study, dapaglifozin was added to metformin alone (group 1, no. 42) or insulin plus metformin (group 2, no. 58) in 100 T2D patients. In group 1, after 6 months of dapaglifozin addition, a significant decrease in BMI (p < 0.001), waist circumference (WC) (p < 0.001), systolic blood pressure (SBP) (p = 0.009), diastolic blood pressure (DBP) (p = 0.012), mean fasting blood glucose (FBG), post-breakfast glucose (PBG), post-lunch glucose (PLG) and post-dinner glucose (PDG) (all p < 0.001), HbA1c (p < 0.001), VAI (p = 0.020), LAP (p = 0.028), Tyg (p < 0.001), TG/HDL-C (p = 0.020) and glutamate pyruvate transaminase (GPT) (p < 0.001) was observed compared to baseline. After 12 months a significant decrease in BMI (p < 0.001), WC (p = 0.006), SBP (p = 0.023), DBP (p = 0.005), mean FPG, PBG, PLG and PDG (all p < 0.001), HbA1c (p < 0.001), total cholesterol (p = 0.038), triglycerides (p = 0.026), VAI (p = 0.013), GPT (p < 0.001), LAP index (p = 0.024), Tyg index (p < 0.001) and TG/HDL-c ratio (p = 0.016) was observed compared to baseline. In group 2, after 6 months of dapaglifozin addition, a significant decrease in BMI (p < 0.001), WC (p < 0.001), SBP (p = 0.015), DBP (p = 0.007), mean FPG, PBG, PLG and PDG (all p < 0.001), HbA1c (p < 0.001), VAI (p = 0.040), LAP (p = 0.047), Tyg (p < 0.001), TG/HDL-C (p = 0.048) and GPT (p < 0.001) was observed compared to baseline. By contrast, after 12 months a significant decrease in BMI (p < 0.001), WC (p < 0.001), SBP (p = 0.001), DBP (p = 0.002), mean FPG, PBG, PLG and PDG (all p < 0.001), HbA1c (p < 0.001), GPT (p < 0.001) and Tyg index (p = 0.003) was observed compared to baseline. Dapagliflozin treatment significantly reduced surrogate indexes of insulin resistance and adiposity in patients with T2D." @default.
• W4244687613 created "2022-05-12" @default.
• W4244687613 creator A5051383358 @default.
• W4244687613 creator A5057659655 @default.
• W4244687613 creator A5064563780 @default.
• W4244687613 creator A5068696057 @default.
• W4244687613 creator A5081242369 @default.
• W4244687613 date "2021-04-30" @default.
• W4244687613 modified "2023-10-09" @default.
• W4244687613 title "One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus" @default.
• W4244687613 cites W1559489829 @default.
• W4244687613 cites W1664963969 @default.
• W4244687613 cites W1967999753 @default.
• W4244687613 cites W1977033970 @default.
• W4244687613 cites W2046820148 @default.
• W4244687613 cites W2062511741 @default.
• W4244687613 cites W2076128320 @default.
• W4244687613 cites W2082683255 @default.
• W4244687613 cites W2089430799 @default.
• W4244687613 cites W2109057881 @default.
• W4244687613 cites W2125944762 @default.
• W4244687613 cites W2133009672 @default.
• W4244687613 cites W2157405334 @default.
• W4244687613 cites W2166613497 @default.
• W4244687613 cites W2167245776 @default.
• W4244687613 cites W2224883440 @default.
• W4244687613 cites W2294512307 @default.
• W4244687613 cites W2460082513 @default.
• W4244687613 cites W2515456868 @default.
• W4244687613 cites W2593682661 @default.
• W4244687613 cites W2626446274 @default.
• W4244687613 cites W2756345767 @default.
• W4244687613 cites W2781483265 @default.
• W4244687613 cites W2890121240 @default.
• W4244687613 cites W2890673765 @default.
• W4244687613 cites W2900413769 @default.
• W4244687613 cites W2921017081 @default.
• W4244687613 cites W2940701722 @default.
• W4244687613 cites W2956038290 @default.
• W4244687613 cites W2972107819 @default.
• W4244687613 cites W2974260792 @default.
• W4244687613 cites W2983908000 @default.
• W4244687613 cites W3080857839 @default.
• W4244687613 cites W3081450473 @default.
• W4244687613 cites W3088173406 @default.
• W4244687613 cites W4230007976 @default.
• W4244687613 cites W4236082454 @default.
• W4244687613 cites W4256525495 @default.
• W4244687613 doi "https://doi.org/10.1007/s13300-021-01056-4" @default.
• W4244687613 hasPublicationYear "2021" @default.
• W4244687613 type Work @default.
• W4244687613 citedByCount "0" @default.
• W4244687613 crossrefType "journal-article" @default.
• W4244687613 hasAuthorship W4244687613A5051383358 @default.
• W4244687613 hasAuthorship W4244687613A5057659655 @default.
• W4244687613 hasAuthorship W4244687613A5064563780 @default.
• W4244687613 hasAuthorship W4244687613A5068696057 @default.
• W4244687613 hasAuthorship W4244687613A5081242369 @default.
• W4244687613 hasBestOaLocation W42446876131 @default.
• W4244687613 hasConcept C126322002 @default.
• W4244687613 hasConcept C134018914 @default.
• W4244687613 hasConcept C2776193436 @default.
• W4244687613 hasConcept C2777180221 @default.
• W4244687613 hasConcept C2777391703 @default.
• W4244687613 hasConcept C2779306644 @default.
• W4244687613 hasConcept C2780221984 @default.
• W4244687613 hasConcept C2780323712 @default.
• W4244687613 hasConcept C2910068830 @default.
• W4244687613 hasConcept C555293320 @default.
• W4244687613 hasConcept C71924100 @default.
• W4244687613 hasConcept C84393581 @default.
• W4244687613 hasConceptScore W4244687613C126322002 @default.
• W4244687613 hasConceptScore W4244687613C134018914 @default.
• W4244687613 hasConceptScore W4244687613C2776193436 @default.
• W4244687613 hasConceptScore W4244687613C2777180221 @default.
• W4244687613 hasConceptScore W4244687613C2777391703 @default.
• W4244687613 hasConceptScore W4244687613C2779306644 @default.
• W4244687613 hasConceptScore W4244687613C2780221984 @default.
• W4244687613 hasConceptScore W4244687613C2780323712 @default.
• W4244687613 hasConceptScore W4244687613C2910068830 @default.
• W4244687613 hasConceptScore W4244687613C555293320 @default.
• W4244687613 hasConceptScore W4244687613C71924100 @default.
• W4244687613 hasConceptScore W4244687613C84393581 @default.
• W4244687613 hasIssue "6" @default.
• W4244687613 hasLocation W42446876131 @default.
• W4244687613 hasLocation W42446876132 @default.
• W4244687613 hasLocation W42446876133 @default.
• W4244687613 hasOpenAccess W4244687613 @default.
• W4244687613 hasPrimaryLocation W42446876131 @default.
• W4244687613 hasRelatedWork W138803513 @default.
• W4244687613 hasRelatedWork W1986132654 @default.
• W4244687613 hasRelatedWork W2010140898 @default.
• W4244687613 hasRelatedWork W2010484394 @default.
• W4244687613 hasRelatedWork W2032225465 @default.
• W4244687613 hasRelatedWork W2082140668 @default.
• W4244687613 hasRelatedWork W2151350502 @default.
• W4244687613 hasRelatedWork W2410789767 @default.
• W4244687613 hasRelatedWork W2744240433 @default.

• next